Inflammatory eye diseases

Israel’s Tarsius (see here) reported positive results in a study of its TRS01 treatment of Active Anterior Non-Infectious Uveitis – an inflammatory eye disease. It shows promise for saving the eyesight of patients with uveitic glaucoma, which has no current approved treatment.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *